$NAVB Navidea Biopharmaceuticals, Inc. NAVB Submitted a Supplemental New Drug Application (sNDA) for Lymphoseek® for Sentinel Lymph Node Dectection in Patients with Head and Neck Cancer - http://yhoo.it/MqMPpA . Should hear back from FDA at end of this month.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.